PTHS insider transactions
Pelthos Therapeutics Inc. (PTHS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for PTHS
- Director Friedberg Ezra M sold $14,556 worth of shares (558 units at $26.09) as part of a pre-agreed trading plan, decreasing direct ownership by 0.68% to 81,042 units (SEC Form 4) to cover withholding tax4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Pauls Matthew sold $20,561 worth of shares (786 units at $26.16) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 14,364 units (SEC Form 4) to satisfy withholding tax4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Greenleaf Peter sold $20,827 worth of shares (797 units at $26.13) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 23,884 units (SEC Form 4) to satisfy withholding tax4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Friedberg Ezra M sold $7,724 worth of shares (283 units at $27.29) as part of a pre-agreed trading plan, decreasing direct ownership by 0.35% to 81,600 units (SEC Form 4) to satisfy tax liability4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Davis Todd C bought $999,983 worth of shares (35,948 units at $27.82), increasing direct ownership by 90% to 75,834 units (SEC Form 4)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- CFO, Treas & Secty Francis Knuettel Ii returned 13,947 shares to the company and sold $40,265 worth of shares (1,500 units at $26.84), decreasing direct ownership by 42% to 19,525 units (SEC Form 4)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Friedberg Ezra M covered exercise/tax liability with 144 shares, decreasing direct ownership by 0.18% to 81,883 units (SEC Form 4) (withholding obligation)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 3 filed by new insider Gay John M.3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Malamut Richard4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Friedberg Ezra M4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Pauls Matthew4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Greenleaf Peter4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Friedberg Ezra M4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Davis Todd C4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Malamut Richard4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Plesha Scott M.4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Greenleaf Peter4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Pauls Matthew4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Rangarao Sai4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Baxter Richard B4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Amendment: SEC Form 4 filed by Francis Knuettel Ii4/A - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Einhorn Andrew J. was granted 12,000 shares (SEC Form 4)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 3 filed by new insider Einhorn Andrew J.3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Pauls Matthew converted options into 10,616 shares and gifted 9,542 shares (SEC Form 4)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- Director Friedberg Ezra M sold $280,280 worth of shares (10,000 units at $28.03) (SEC Form 4)4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Director Ligand Pharmaceuticals Inc4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by CEO and President Plesha Scott M.4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 3 filed by new insider Plesha Scott M.3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Rangarao Sai4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
- SEC Form 3 filed by new insider Rangarao Sai3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)